Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with approximately 51,000 employees. Family-owned since 1885, the company creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.
Our Immunology disease research combines our proven ability to address unmet medical needs with pioneering patient-centered approaches to accelerate the discovery of breakthrough therapies. Our teams are focused on the discovery and development of new therapeutic concepts that will radically alter the progression of chronic inflammatory and autoimmune diseases.
For more information, please visit our virtual Medical booth experience.